image
Healthcare - Medical - Devices - OTC - US
$ 0.5199
-10.6 %
$ 13.1 M
Market Cap
-1.21
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one PETV stock under the worst case scenario is HIDDEN Compared to the current market price of 0.52 USD, PetVivo Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one PETV stock under the base case scenario is HIDDEN Compared to the current market price of 0.52 USD, PetVivo Holdings, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 23, 2025.

The intrinsic value of one PETV stock under the best case scenario is HIDDEN Compared to the current market price of 0.52 USD, PetVivo Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PETV

image
$1.0$1.0$0.9$0.9$0.8$0.8$0.7$0.7$0.6$0.6$0.5$0.5$0.4$0.4Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
969 K REVENUE
5.62%
-10.6 M OPERATING INCOME
-21.62%
-11 M NET INCOME
-25.67%
-7.42 M OPERATING CASH FLOW
-9.20%
-309 K INVESTING CASH FLOW
27.09%
7.34 M FINANCING CASH FLOW
362.59%
583 K REVENUE
190.61%
-1.76 M OPERATING INCOME
19.08%
-1.76 M NET INCOME
19.23%
-961 K OPERATING CASH FLOW
39.93%
-23.6 K INVESTING CASH FLOW
-590.99%
888 K FINANCING CASH FLOW
-48.33%
Balance Sheet PetVivo Holdings, Inc.
image
Current Assets 1.04 M
Cash & Short-Term Investments 87.4 K
Receivables 18.7 K
Other Current Assets 936 K
Non-Current Assets 2.07 M
Long-Term Investments 0
PP&E 2.02 M
Other Non-Current Assets 57.6 K
2.81 %30.03 %64.71 %Total Assets$3.1m
Current Liabilities 1.41 M
Accounts Payable 821 K
Short-Term Debt 348 K
Other Current Liabilities 243 K
Non-Current Liabilities 1.02 M
Long-Term Debt 1.02 M
Other Non-Current Liabilities 0
33.81 %14.33 %10.00 %41.86 %Total Liabilities$2.4m
EFFICIENCY
Earnings Waterfall PetVivo Holdings, Inc.
image
Revenue 969 K
Cost Of Revenue 229 K
Gross Profit 740 K
Operating Expenses 11.4 M
Operating Income -10.6 M
Other Expenses 334 K
Net Income -11 M
2m2m00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)969k(229k)740k(11m)(11m)(334k)(11m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
76.34% GROSS MARGIN
76.34%
-1096.45% OPERATING MARGIN
-1096.45%
-1130.92% NET MARGIN
-1130.92%
-1597.09% ROE
-1597.09%
-351.67% ROA
-351.67%
-517.86% ROIC
-517.86%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis PetVivo Holdings, Inc.
image
00(1m)(1m)(2m)(2m)(3m)(3m)(4m)(4m)(5m)(5m)(6m)(6m)(7m)(7m)(8m)(8m)201620162017201720182018201920192020202020212021202220222023202320242024
Net Income -11 M
Depreciation & Amortization 127 K
Capital Expenditures -309 K
Stock-Based Compensation 2.63 M
Change in Working Capital 172 K
Others 648 K
Free Cash Flow -7.73 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets PetVivo Holdings, Inc.
image
PETV has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership PetVivo Holdings, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades (“Eq Especialidades”). Eq Especialidades will inventory, market and promote PetVivo's veterinary medical device, Spryng™ with OsteoCushion™ technology, throughout Mexico. Eq Especialidades sales and marketing activities will commence on April 1, 2025. globenewswire.com - 2 weeks ago
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock (“Shares”) (the “Offering”). The Company initially received Six Hundred Thousand Dollars ($600,000) of the Offering proceeds on March 26, 2025 with the investor receiving an option to invest the remaining Four Million Four Hundred Thousand Dollars ($4,400,000), which is anticipated to be received within the next sixty days. globenewswire.com - 1 month ago
Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) (the "Company" or “PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for animals and Digital Landia Corp. a pioneer in Agentic AI solutions, today announced a transformative strategic alliance agreement. The collaboration centers on Pet AI, Digital Landia's revolutionary open-source platform that deciphers animal behavior through real-time analysis of vocalizations, body language, and physiological signals captured via smartphone cameras. This technology, which achieves 97% accuracy in translating animal communication, will integrate Petvivo's veterinary products into a first-of-its-kind global pet care ecosystem. globenewswire.com - 1 month ago
Petvivo Holdings, Inc. to Exhibit at the Western Veterinary Conference in Las Vegas, Nevada MINNEAPOLIS, Feb. 19, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the Western Veterinary Conference to be held March 2nd to March 5th, 2025 at the Mandalay Bay Convention Center in Las Vegas, Nevada. globenewswire.com - 2 months ago
PetVivo Reports Fiscal Q3 2025 Results MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion animals, reported results for its fiscal third quarter ended December 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. globenewswire.com - 2 months ago
PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License and Supply Agreement with VetStem, Inc. to commercialize VetStem's innovative allogeneic orthobiologic products, PrecisePRP® canine and PrecisePRP® equine. PrecisePRP® is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. globenewswire.com - 2 months ago
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and OTCPINK: PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Friday, February 14, 2025 after market close. The company will host a conference call to discuss these results at 2:00 p.m. CT (3:00 p.m. ET) on the same day. globenewswire.com - 2 months ago
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor PetVivo Board Appoints Eldred as Executive Director to Lead Company  Product Commercialization and Operations globenewswire.com - 3 months ago
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025 MINNEAPOLIS, MN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals today announced it will be exhibiting at the Veterinary Meeting & Expo Conference to held from January 25th to January 29th, 2025, at the Orange County Convention Center, Exhibit Halls B, C and D, in Orlando, Florida. globenewswire.com - 3 months ago
PETVIVO HOLDING, INC. ANNOUNCES PARTNERSHIP ENGAGEMENTS WITH VEDCO, INC. MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) ("PetVivo"), a pioneering biomedical technology company focused on adapting human biotech, medical device and other therapeutic technologies into osteoarthritis and lameness products for commercial sale in the US companion animal and equine markets, announces new distribution partnerships with Vedco Inc. (“Vedco”), and Clipper Distributing, LLC (“Clipper”), both leaders in logistical solutions and supply of products to veterinarians through the channel-of-distribution for veterinarians. Vedco and Clipper distribute to many of the largest national veterinary product distribution entities in the United States, including MWI, Covetrus, Patterson, Midwest Supply and Penn Supply, to just name a few. globenewswire.com - 3 months ago
PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025 MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will host a live webcast Shareholders Update Meeting to provide an overview of the Company's progress in the 2025 fiscal year and a look into the potential future of the Company. The Shareholders Update Meeting: 2025 Company Overview will be held on Wednesday, January 8, 2025 at 3:30 p.m. CT (4:30 p.m. ET). globenewswire.com - 4 months ago
PetVivo Holdings, Inc. Announces Participation in The Microcap Conference 2025 MINNEAPOLIS, MN / ACCESSWIRE / December 19, 2024 / PetVivo Holdings, Inc. (OTCQB:PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. accesswire.com - 4 months ago
8. Profile Summary

PetVivo Holdings, Inc. PETV

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 13.1 M
Dividend Yield 0.00%
Description PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Contact 5251 Edina Industrial Boulevard, Minneapolis, MN, 55439 https://www.petvivo.com
IPO Date Sept. 8, 2014
Employees 20
Officers Mr. John F. Dolan General Counsel, Chief Business Development Officer & Secretary Mr. Michael Eldred BA, MBA Commercialization & Operations Advisor and Executive Director Mr. Garry N. Lowenthal Chief Financial Officer Ms. April Boyce Vice President of Sales & Marketing Mr. John Lai Chief Executive Officer, President & Director